news update: sanofi-aventis takeover of genzyme unlikely, analysts say - shares down
Published 13 years ago • 6.1K plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
4:45
sanofi's viehbacher says genzyme must justify higher bid: video
-
0:57
news update: sanofi-aventis denies genzyme acquisition price range rumors
-
2:25
sanofi agrees to acquire genzyme for $20.1 billion
-
2:52
genzyme investors push for sanofi bid of $75 a share: video
-
0:53
sanofi eyes hostile genzyme bid; posco buys daewoo stake: video
-
5:35
to ignore robotaxis is a huge mistake with tesla's stock, says ark invest's tasha keeney
-
3:07
anz discusses the headwinds that could affect india's economic growth for financial year 2025
-
3:31
trade school: what to do with crowdstrike
-
4:00
porges says genzyme management seeking `graceful exit': video
-
0:36
news update: genzyme spikes on report sanofi-aventis interested in acquiring company
-
1:28
viehbacher says sanofi-genzyme talks had `some progress': video
-
1:39
genzyme shares down for fifth straight day - bloomberg
-
4:01
comte says sanofi will be able to retain genzyme talent
-
1:09
what's in the news: august 3, 2010: sanofi-aventis in talks to take over genzyme
-
1:12
ge to buy wellstream; sanofi extends genzyme offer
-
4:31
blocking the horizon-amgen deal will be worse for pharma than for biotech, says mizuho's jared holz
-
1:02
dan lyons explains sanofi genzyme’s approach to pricing novel products
-
3:07
socgen chairman: reducing inflation will impact the economy
-
5:42
this week triggered a capitulation of investor consensus, says virtus investment's joe terranova
-
1:03
novavax surges on $1.2 billion sanofi vaccine deal
-
0:43
news update: sanofi-aventis sues fda to withdraw approval of competing low-cost blood thinning drug
-
2:45
wieting: be careful investing as volatility in various sectors increases